These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 13767183)
1. Streptonigrin, an antitumor agent produced by strains of Streptomyces flocculus. I. Microbiological studies. MARSH WS; GARRETSON AL; WESEL EM Antibiot Chemother (Northfield); 1961 Mar; 11():151-7. PubMed ID: 13767183 [No Abstract] [Full Text] [Related]
2. A novel streptonigrin type alkaloid from the Wang X; Xu F; Huang T; Deng Z; Lin S Nat Prod Res; 2022 Jul; 36(13):3337-3345. PubMed ID: 33280413 [TBL] [Abstract][Full Text] [Related]
3. A tryptophan C-methyltransferase involved in streptonigrin biosynthesis in Streptomyces flocculus. Hartley DL; Speedie MK Biochem J; 1984 May; 220(1):309-13. PubMed ID: 6743267 [TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of S-adenosylhomocysteine deaminase from streptonigrin-producing Streptomyces flocculus. Zulty JJ; Speedie MK J Bacteriol; 1989 Dec; 171(12):6840-4. PubMed ID: 2592350 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of a metabolic grid at an early step in the streptonigrin biosynthetic pathway in Streptomyces flocculus. Speedie MK; Hartley DL J Antibiot (Tokyo); 1984 Feb; 37(2):159-66. PubMed ID: 6706852 [TBL] [Abstract][Full Text] [Related]
6. Chemistry, Biosynthesis and Pharmacology of Streptonigrin: An Old Molecule with Future Prospects for New Drug Design, Development and Therapy. Nabihah Nasir N; Sekar M; Ravi S; Wong LS; Sisinthy SP; Gan SH; Subramaniyan V; Chidambaram K; Mat Rani NNI; Begum MY; Ramar M; Safi SZ; Selvaraj S; Chinna Maruthu SK; Fuloria S; Fuloria NK; Lum PT; Djearamane S Drug Des Devel Ther; 2023; 17():1065-1078. PubMed ID: 37064433 [TBL] [Abstract][Full Text] [Related]
7. Identification of (2S,3S)-β-Methyltryptophan as the Real Biosynthetic Intermediate of Antitumor Agent Streptonigrin. Kong D; Zou Y; Zhang Z; Xu F; Brock NL; Zhang L; Deng Z; Lin S Sci Rep; 2016 Feb; 6():20273. PubMed ID: 26847951 [TBL] [Abstract][Full Text] [Related]
8. Preliminary observations on the use of streptonigrin as an antitumor agent in human beings. WILSON WL; LABRA C; BARRIST E Antibiot Chemother (Northfield); 1961 Mar; 11():147-50. PubMed ID: 13785724 [No Abstract] [Full Text] [Related]
9. Xantholipin B produced by the stnR inactivation mutant Streptomyces flocculus CGMCC 4.1223 WJN-1. Wu S; Huang T; Xie D; Wo J; Wang X; Deng Z; Lin S J Antibiot (Tokyo); 2017 Jan; 70(1):90-95. PubMed ID: 27328868 [TBL] [Abstract][Full Text] [Related]
10. Characterization of streptonigrin biosynthesis reveals a cryptic carboxyl methylation and an unusual oxidative cleavage of a N-C bond. Xu F; Kong D; He X; Zhang Z; Han M; Xie X; Wang P; Cheng H; Tao M; Zhang L; Deng Z; Lin S J Am Chem Soc; 2013 Feb; 135(5):1739-48. PubMed ID: 23301954 [TBL] [Abstract][Full Text] [Related]
11. Isolation of 4-aminoanthranilic acid: a new shikimate pathway product from Streptomyces flocculus. Gould SJ; Erickson WR J Antibiot (Tokyo); 1988 May; 41(5):688-9. PubMed ID: 3384755 [No Abstract] [Full Text] [Related]
12. Streptonigrin, an antitumor substance. I. Isolation and characterization. RAO KV; CULLEN WP Antibiot Annu; 1959-1960; 7():950-3. PubMed ID: 14436228 [No Abstract] [Full Text] [Related]
13. Significance of agitation-induced shear stress on mycelium morphology and lavendamycin production by engineered Streptomyces flocculus. Xia X; Lin S; Xia XX; Cong FS; Zhong JJ Appl Microbiol Biotechnol; 2014 May; 98(10):4399-407. PubMed ID: 24522728 [TBL] [Abstract][Full Text] [Related]